Chemitope Glycopeptide is a biotechnology company based in Brooklyn that specializes in the chemical synthesis of glycopeptides for research and clinical development. With expertise in carbohydrate and peptide chemistry, we have the unique ability to control the atomic-level structure and produce homogeneous complex glycopeptides. Our focus is on utilizing glycosylation in cancer and infectious diseases to develop glycopeptide immunogens for therapeutic and preventative vaccine applications.

In addition to our research and development efforts, we offer comprehensive chemical synthesis and pre-clinical manufacturing support to our partners in academia, biotech, and the pharmaceutical industry. Our CEO and co-founder, Dr. Baptiste Aussedat, is a leading expert in peptide and glycopeptide chemistry with over 18 years of experience.

His groundbreaking research has significantly improved the efficiency of N-linked glycopeptide synthesis. Prior to starting Chemitope, Dr. Aussedat worked at Memorial Sloan Kettering Cancer Center, where he synthesized glycopeptide immunogens for prestigious organizations like the Duke CHAVI-ID consortium and the NIH Vaccine Research Center.

With Chemitope Glycopeptide, you can trust in our expertise and dedication to advancing glycopeptide research and development for the betterment of healthcare